Delivery Order SPE2DB22D2006-SPE2DB25FV5YW

Award Date 10/30/24
Potential Completion Date 11/21/24
Potential Value $8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.85 firm fixed-price delivery order is for the supply of ORGOVYX 120 MG TABLET medication. The contract has an ultimate completion date of December 11, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.85 Firm Fixed Price Delivery Order is for the supply of ORGOVYX 120 MG TABLET, a pharmaceutical product, with a period of performance through January 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.85 firm fixed-price delivery order contract is for the supply of ORGOVYX 120 MG TABLET, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $1,375.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORGOVYX 120 MG TABLET, a medical product, to support DLA's medical supply and pharmaceutical needs. The contract is a Firm Fixed Price Delivery Order with a completion date of January 29, 2025. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,313.12 firm fixed-price delivery order contract is for the supply of ORGOVYX 120 MG TABLET medication, with a completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order is for the pharmaceutical product ORGOVYX 120 MG TABLET, with an ultimate completion date of April 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,989.67 firm fixed-price delivery order is for the supply of ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of December 3, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award, valued at $1,375.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ORGOVYX 120 MG TABLET UU 30S, a medical product, with a completion date of December 13, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,329.89 firm fixed-price delivery order is for the supply of ORGOVYX 120 MG TABLET medical product. The contract has an ultimate completion date of November 14, 2024 and was awarded on October 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order contract, awarded on February 19, 2025, is for the supply of ORGOVYX 120 MG TABLET medication with a performance period through March 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV5YW
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $7,979.34 delivery order is for the supply of ORGOVYX 120 MG TABLET medical products. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with DLA Troop Support Medical, which provides a range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a completion date of November 21, 2024 and is structured as a firm fixed-price delivery order. No set-aside designations were used for this award.

Generated 1/29/25, 9:14 AM